{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:29:34Z","timestamp":1761200974076,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.biocel.2008.03.002","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T00:52:40Z","timestamp":1206060760000},"page":"1643-1648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment"],"prefix":"10.1016","volume":"40","author":[{"given":"Michael V.G.","family":"Latronico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Catalucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biocel.2008.03.002_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.RES.0000147557.75257.ff","article-title":"Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes","volume":"95","author":"Alcendor","year":"2004","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.biocel.2008.03.002_bib0010","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.biocel.2008.03.002_bib0015","doi-asserted-by":"crossref","first-page":"28930","DOI":"10.1074\/jbc.M303113200","article-title":"Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors","volume":"278","author":"Antos","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2008.03.002_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","article-title":"Control of cardiac growth by histone acetylation\/deacetylation","volume":"98","author":"Backs","year":"2006","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.biocel.2008.03.002_bib0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biocel.2008.03.002_bib0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Car\u00e8","year":"2007","journal-title":"Nat Med"},{"issue":"28","key":"10.1016\/j.biocel.2008.03.002_bib0035","doi-asserted-by":"crossref","first-page":"19369","DOI":"10.1074\/jbc.M601443200","article-title":"Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha","volume":"281","author":"Chen","year":"2006","journal-title":"J Biol Chem"},{"issue":"7119","key":"10.1016\/j.biocel.2008.03.002_bib0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/444566a","article-title":"Oenology: red wine procyanidins and vascular health","volume":"444","author":"Corder","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2008.03.002_bib0045","doi-asserted-by":"crossref","first-page":"H1477","DOI":"10.1152\/ajpheart.00789.2004","article-title":"Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility","volume":"288","author":"Davis","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.biocel.2008.03.002_bib0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/hc0102.101365","article-title":"Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress","volume":"105","author":"Esposito","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2008.03.002_bib0055","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biocel.2008.03.002_bib0060","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physiolgenomics.00144.2007","article-title":"Altered microRNA expression in human heart disease","volume":"31","author":"Ikeda","year":"2007","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.biocel.2008.03.002_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/heart.87.3.235","article-title":"Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables","volume":"87","author":"Juenger","year":"2002","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.biocel.2008.03.002_bib0070","doi-asserted-by":"crossref","first-page":"H2138","DOI":"10.1152\/ajpheart.00852.2006","article-title":"Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol","volume":"292","author":"Juric","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.biocel.2008.03.002_bib0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.0000176028.18423.07","article-title":"Genome-wide screening for target regions of histone deacetylases in cardiomyocytes","volume":"97","author":"Kaneda","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.biocel.2008.03.002_bib0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2008.03.002_bib0085","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biocel.2008.03.002_bib0090","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCRESAHA.107.163147","article-title":"Emerging role of microRNAs in cardiovascular biology","volume":"101","author":"Latronico","year":"2007","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.biocel.2008.03.002_bib0095","first-page":"1049","article-title":"Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model","volume":"32","author":"Liu","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.biocel.2008.03.002_bib0100","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"10","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2008.03.002_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.med.53.082901.104004","article-title":"New therapeutics for chronic heart failure","volume":"53","author":"Mann","year":"2002","journal-title":"Ann Rev Med"},{"issue":"1","key":"10.1016\/j.biocel.2008.03.002_bib0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/MCB.23.1.38-54.2003","article-title":"The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis","volume":"23","author":"McBurney","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biocel.2008.03.002_bib0115","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2008.03.002_bib0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/092986707779313354","article-title":"Left ventricular hypertrophy: a shift in paradigm","volume":"14","author":"Meijs","year":"2007","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.biocel.2008.03.002_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"Michan","year":"2007","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.biocel.2008.03.002_bib0130","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1078-0432.CCR-06-1715","article-title":"HDAC inhibitors and cardiac safety","volume":"13","author":"Molife","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.biocel.2008.03.002_bib0135","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.biocel.2008.03.002_bib0140","doi-asserted-by":"crossref","first-page":"43121","DOI":"10.1074\/jbc.M506162200","article-title":"Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity","volume":"280","author":"Pillai","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.biocel.2008.03.002_bib0145","doi-asserted-by":"crossref","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","article-title":"Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy","volume":"291","author":"Pillai","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.biocel.2008.03.002_bib0150","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01339.2007","article-title":"Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding mediated induction of the {alpha}-myosin heavy chain expression","author":"Pillai","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.biocel.2008.03.002_bib0155","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1001\/archinte.159.16.1865","volume":"159","author":"Renaud","year":"1999","journal-title":"Arch Int Med"},{"issue":"48","key":"10.1016\/j.biocel.2008.03.002_bib0160","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2008.03.002_bib0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00001573-199605000-00002","article-title":"Molecular and cellular biology of heart failure","volume":"11","author":"Schwartz","year":"1996","journal-title":"Curr Opin Cardiol"},{"issue":"13","key":"10.1016\/j.biocel.2008.03.002_bib0170","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1158\/1078-0432.CCR-05-2689","article-title":"Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors","volume":"12","author":"Shah","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biocel.2008.03.002_bib0175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0024-3205(02)01691-0","article-title":"Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats","volume":"71","author":"Sinha","year":"2002","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.biocel.2008.03.002_bib0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More \u2018malignant\u2019 than cancer? Five-year survival following a first admission for heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.biocel.2008.03.002_bib0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","article-title":"Histone deacetylases: unique players in shaping the epigenetic histone code","volume":"983","author":"Thiagalingam","year":"2003","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"10.1016\/j.biocel.2008.03.002_bib0190","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","article-title":"MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure","volume":"116","author":"Thum","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biocel.2008.03.002_bib0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2005.10.004","article-title":"Antisense molecules for targeted cancer therapy","volume":"59","author":"Wacheck","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.biocel.2008.03.002_bib0200","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2008.03.002_bib0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272508001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272508001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:28:35Z","timestamp":1761200915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272508001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1357272508001167"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2008.03.002","relation":{},"ISSN":["1357-2725"],"issn-type":[{"type":"print","value":"1357-2725"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2008.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}